M. Schwartz

4.4k total citations · 2 hit papers
44 papers, 2.9k citations indexed

About

M. Schwartz is a scholar working on Hepatology, Oncology and Surgery. According to data from OpenAlex, M. Schwartz has authored 44 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Hepatology, 15 papers in Oncology and 11 papers in Surgery. Recurrent topics in M. Schwartz's work include Hepatocellular Carcinoma Treatment and Prognosis (17 papers), Organ Transplantation Techniques and Outcomes (7 papers) and Cancer Immunotherapy and Biomarkers (5 papers). M. Schwartz is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (17 papers), Organ Transplantation Techniques and Outcomes (7 papers) and Cancer Immunotherapy and Biomarkers (5 papers). M. Schwartz collaborates with scholars based in United States, Spain and Denmark. M. Schwartz's co-authors include Josep M. Llovet, Gregory J. Gores, Jessica Zucman‐Rossi, Eli Pikarsky, Bruno Sangro, Morris Sherman, Swan N. Thung, Scott L. Friedman, Vincenzo Mazzaferro and Juan Putra and has published in prestigious journals such as Journal of Clinical Oncology, Gastroenterology and JNCI Journal of the National Cancer Institute.

In The Last Decade

M. Schwartz

41 papers receiving 2.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Hepatocellular carcinoma

2016 1.9k citations Josep M. Llovet, Jessica Zucman‐Rossi et al. Nature Reviews Disease Primers profile →
Identification of an Immune-specific Class of Hepatocellular Carcinoma, Based on Molecular Features

2017 632 citations Daniela Sia, Yang Jiao et al. Gastroenterology profile →

Peers

M. Schwartz

HEPAT

ONCOL

EPIDE

Enrico N. De Toni Germany

Renumathy Dhanasekaran United States

Romilda Cardin Italy

Hong‐Yang Wang China

Gar‐Yang Chau Taiwan

Arndt Weinmann Germany

Andrea Casadei‐Gardini Italy

Thomas Decaens France

Kazuhiro Nouso Japan

Enrico N. De Toni Germany

M. Schwartz

1.1k ×1.0

HEPAT

1.3k ×1.2

627 ×0.8

1.2k ×1.5

ONCOL

712 ×1.1

EPIDE

Citations per year, relative to M. Schwartz M. Schwartz (= 1×) peers Enrico N. De Toni

Countries citing papers authored by M. Schwartz

Since Specialization

Citations

This map shows the geographic impact of M. Schwartz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Schwartz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Schwartz more than expected).

Fields of papers citing papers by M. Schwartz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Schwartz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Schwartz. The network helps show where M. Schwartz may publish in the future.

Co-authorship network of co-authors of M. Schwartz

This figure shows the co-authorship network connecting the top 25 collaborators of M. Schwartz. A scholar is included among the top collaborators of M. Schwartz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Schwartz. M. Schwartz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Stocker, Daniel, Michael J. King, Maria El Homsi, et al.. (2023). Early post-treatment MRI predicts long-term hepatocellular carcinoma response to radiation segmentectomy. European Radiology. 34(1). 475–484. 6 indexed citations

Marron, Thomas U., M. Schwartz, Virginia Corbett, & Miriam Mérad. (2022). Neoadjuvant Immunotherapy for Hepatocellular Carcinoma. Journal of Hepatocellular Carcinoma. Volume 9. 571–581. 16 indexed citations

Lewis, Sara, Mario A. Cedillo, Karen M. Lee, et al.. (2021). Comparative assessment of standard and immune response criteria for evaluation of response to PD-1 monotherapy in unresectable HCC. Abdominal Radiology. 47(3). 969–980. 8 indexed citations

Dharmapuri, Sirish, et al.. (2019). Outcomes of hepatocellular carcinoma (HCC) patients treated with nivolumab: The Mount Sinai Hospital experience. Annals of Oncology. 30. v294–v294. 3 indexed citations

Dharmapuri, Sirish, et al.. (2019). Predictive value of neutrophil-lymphocyte ratio (NLR) and platelet-lymphocyte ratio (PLR) In hepatocellular carcinoma (HCC) patients treated with nivolumab (N). Annals of Oncology. 30. v285–v286. 2 indexed citations

Labgaa, Ismaïl, et al.. (2018). Radioembolization with Y90 as bridge to liver transplantation or resection for intermediate stage hepatocellular carcinoma. HPB. 20. S257–S257.

Sia, Daniela, Yang Jiao, Iris Martinez-Quetglas, et al.. (2017). Identification of an Immune-specific Class of Hepatocellular Carcinoma, Based on Molecular Features. Gastroenterology. 153(3). 812–826. 632 indexed citations breakdown →

Llovet, Josep M., Jessica Zucman‐Rossi, Eli Pikarsky, et al.. (2016). Hepatocellular carcinoma. Nature Reviews Disease Primers. 2(1). 16018–16018. 1876 indexed citations breakdown →

Titano, J., Thomas J. Ward, Elisa Sefora Pierobon, et al.. (2014). Transarterial Chemoembolization Outcomes in Downstaging Hepatocellular Carcinoma Patients beyond the Milan Criteria. Journal of Vascular and Interventional Radiology. 26(1). 150–150. 1 indexed citations

10.

Wynne, Jacob, L.A. Modlin, Andrea Fan, et al.. (2013). Analysis of Circulating Tumor Cells in Early Stage Non-Small Cell Lung Cancer Patients Treated With Stereotactic Ablative Radiation Therapy. International Journal of Radiation Oncology*Biology*Physics. 87(2). S200–S201. 3 indexed citations

11.

Sherman, Marc S., Matteo Colombo, Bin Cui, et al.. (2009). HCC BRIDGE study : BRIDGE to better outcomes in hepatocellular carcinoma. 2 indexed citations

12.

Silverberg, Daniel, Shalini Arora, Philippa Newell, et al.. (2007). Establishing an International Training Program for Surgical Residents. Journal of surgical education. 64(3). 143–149. 25 indexed citations

13.

Schwartz, Jonathan D., M. Schwartz, Deborah Lehrer, et al.. (2006). Bevacizumab in unresectable hepatocellular carcinoma (HCC) for patients without metastasis and without invasion of the portal vein. Journal of Clinical Oncology. 24(18_suppl). 4144–4144. 38 indexed citations

14.

Higgins, Peter, et al.. (2005). 8 IS ENDOSCOPY NECESSARY FOR THE MEASUREMENT OF DISEASE ACTIVITY IN ULCERATIVE COLITIS?. Journal of Investigative Medicine. 53(2). S388.2–S388. 4 indexed citations

15.

Suehiro, Taketoshi, Péter Boros, Sukru Emre, et al.. (1997). Value of caval effluent in predicting early graft function after orthotopic liver transplantation. Transplantation Proceedings. 29(1-2). 469–470. 10 indexed citations

16.

Schwartz, M., et al.. (1996). [A follow-up study of carriers of cystic fibrosis].. PubMed. 158(33). 4623–7. 4 indexed citations

17.

Sutnick, A. I., Paula L. Stillman, John J. Norcini, et al.. (1994). Pilot study of the use of the ECFMG clinical competence assessment to provide profiles of clinical competencies of graduates of foreign medical schools for residency directors. Educational Commission for Foreign Medical Graduates. Academic Medicine. 69(1). 65–7. 11 indexed citations

18.

Theise, Neil D., et al.. (1993). Biliary cystadenocarcinoma arising in a liver with fibropolycystic disease.. PubMed. 117(2). 163–5. 7 indexed citations

19.

Pihl, E., Birger Jansson, M. Schwartz, et al.. (1982). Germinal centre hyperplasia: An unfavourable immune response in recurrent malignant melanoma. Pathology. 14(1). 13–16. 2 indexed citations

20.

Schwartz, M., et al.. (1952). A.P.F. in Megaloblastic Anaemia. BMJ. 2(4784). 612.2–613. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact